Evaluation of anhydrohexitol nucleic acid, cyclohexenyl nucleic acid and d-altritol nucleic acid-modified 2′-O-methyl RNA mixmer antisense oligonucleotides for …
Antisense oligonucleotide (AO) mediated exon skipping has been widely explored as a
therapeutic strategy for several diseases, in particular, for rare genetic disorders such as …
therapeutic strategy for several diseases, in particular, for rare genetic disorders such as …
Evaluation of anhydrohexitol nucleic acid, cyclohexenyl nucleic acid andd-altritol nucleic acid-modified 2′-O-methyl RNA mixmer antisense oligonucleotides for …
BT Le, S Chen, M Abramov, P Herdewijn… - Chemical …, 2016 - cir.nii.ac.jp
Evaluation of anhydrohexitol nucleic acid, cyclohexenyl nucleic acid and<scp>d</scp>-altritol
nucleic acid-modified 2′-O-methyl RNA mixmer antisense oligonucleotides for exon skipping …
nucleic acid-modified 2′-O-methyl RNA mixmer antisense oligonucleotides for exon skipping …
Evaluation of anhydrohexitol nucleic acid, cyclohexenyl nucleic acid and d-altritol nucleic acid-modified 2'-O-methyl RNA mixmer antisense oligonucleotides for exon …
BT Le, S Chen, M Abramov, P Herdewijn… - Chemical …, 2016 - europepmc.org
Antisense oligonucleotide (AO) mediated exon skipping has been widely explored as a
therapeutic strategy for several diseases, in particular, for rare genetic disorders such as …
therapeutic strategy for several diseases, in particular, for rare genetic disorders such as …
Evaluation of anhydrohexitol nucleic acid, cyclohexenyl nucleic acid and d-altritol nucleic acid-modified 2′-O-methyl RNA mixmer antisense oligonucleotides for …
BT Le, S Chen, M Abramov… - Chemical …, 2016 - researchportal.murdoch.edu.au
Antisense oligonucleotide (AO) mediated exon skipping has been widely explored as a
therapeutic strategy for several diseases, in particular, for rare genetic disorders such as …
therapeutic strategy for several diseases, in particular, for rare genetic disorders such as …
Evaluation of anhydrohexitol nucleic acid, cyclohexenyl nucleic acid and d-altritol nucleic acid-modified 2'-O-methyl RNA mixmer antisense oligonucleotides for exon …
BT Le, S Chen, M Abramov… - Chemical …, 2016 - pubmed.ncbi.nlm.nih.gov
Antisense oligonucleotide (AO) mediated exon skipping has been widely explored as a
therapeutic strategy for several diseases, in particular, for rare genetic disorders such as …
therapeutic strategy for several diseases, in particular, for rare genetic disorders such as …